M6A ‐Mediated Stabilization of RGS1 Drives Keloid Formation by Activating Inflammatory Response and Oxidative Stress

Keloids are fibroproliferative skin disorders with limited therapeutic options. Epigenetic regulation, particularly N6-methyladenosine (m6A) modification, along with inflammatory signaling, is increasingly implicated in their pathogenesis. By analyzing three keloid expression datasets (GSE151464, GSE212954, GSE188952), we identified regulator of G-protein signaling 1 (RGS1) as a consistently upregulated target. Both RGS1 and the m6A methyltransferase METTL3 were significantly elevated in clinical keloid tissues and primary fibroblasts, showing a positive correlation. MeRIP-qPCR confirmed abundant m6A modifications on RGS1 mRNA. Silencing METTL3 reduced m6A modification and stability of RGS1 mRNA, whereas RGS1 overexpression did not alter METTL3 levels. In keloid fibroblasts, RGS1 overexpression activated the NF-κB pathway, enhanced the secretion of IL-1β, TNF-α, and IL-6, elevated reactive oxygen species (ROS), and suppressed antioxidant proteins NQO1 and HO-1. These effects were reversed by pyrrolidine dithiocarbamate (PDTC), an NF-κB inhibitor. METTL3 knockdown also impaired fibroblast proliferation, migration, invasion, and reduced fibrosis markers α-SMA, Vimentin, and COL1, all rescued by RGS1 overexpression. In a xenograft model, RGS1 overexpression accelerated lesion growth and systemic inflammation, which PDTC treatment attenuated. In summary, METTL3-mediated m6A modification stabilizes RGS1 mRNA, promoting keloid progression through NF-κB-dependent inflammation and oxidative stress, highlighting the METTL3/RGS1/NF-κB axis as a promising therapeutic target.

Authors

Institutions

Publication Details

Journal
The FASEB Journal
Published
2026-11-14
DOI
https://doi.org/10.1096/fj.202603274r
Primary Topic
Dermatologic Treatments and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

M6A ‐Mediated Stabilization of RGS1 Drives Keloid Formation by Activating Inflammatory Response and Oxidative Stress

Xingong Lin, Mingmeng Pan, Chaoyang Wang, Tianzi Hong et al.
The FASEB Journal
Dermatologic Treatments and Research
article

M6A ‐Mediated Stabilization of RGS1 Drives Keloid Formation by Activating Inflammatory Response and Oxidative Stress

Xingong Lin, Mingmeng Pan, Chaoyang Wang, Tianzi Hong, Rongrong Xie, Xianying Zhou, Yanyan Huang, Yuping Lin, Long Xie
article en

Abstract

Keloids are fibroproliferative skin disorders with limited therapeutic options. Epigenetic regulation, particularly N6-methyladenosine (m6A) modification, along with inflammatory signaling, is increasingly implicated in their pathogenesis. By analyzing three keloid expression datasets (GSE151464, GSE212954, GSE188952), we identified regulator of G-protein signaling 1 (RGS1) as a consistently upregulated target. Both RGS1 and the m6A methyltransferase METTL3 were significantly elevated in clinical keloid tissues and primary fibroblasts, showing a positive correlation. MeRIP-qPCR confirmed abundant m6A modifications on RGS1 mRNA. Silencing METTL3 reduced m6A modification and stability of RGS1 mRNA, whereas RGS1 overexpression did not alter METTL3 levels. In keloid fibroblasts, RGS1 overexpression activated the NF-κB pathway, enhanced the secretion of IL-1β, TNF-α, and IL-6, elevated reactive oxygen species (ROS), and suppressed antioxidant proteins NQO1 and HO-1. These effects were reversed by pyrrolidine dithiocarbamate (PDTC), an NF-κB inhibitor. METTL3 knockdown also impaired fibroblast proliferation, migration, invasion, and reduced fibrosis markers α-SMA, Vimentin, and COL1, all rescued by RGS1 overexpression. In a xenograft model, RGS1 overexpression accelerated lesion growth and systemic inflammation, which PDTC treatment attenuated. In summary, METTL3-mediated m6A modification stabilizes RGS1 mRNA, promoting keloid progression through NF-κB-dependent inflammation and oxidative stress, highlighting the METTL3/RGS1/NF-κB axis as a promising therapeutic target.

The FASEB JournalVol. 40(22)
Fujian Medical University (CN), Second Affiliated Hospital of Fujian Medical University (CN)
Dermatologic Treatments and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon